Agency Agreements in the Health Care Equipment & Supplies Industry
86 Contracts & Agreements
- Accelerate Diagnostics, Inc (1 contract)
- Alphatec Holdings, Inc. (3)
- Avinger Inc (1)
- BARRIER THERAPEUTICS INC (1)
- BIOLASE, INC (3)
- BIOLIFE SOLUTIONS INC (1)
- CESCA THERAPEUTICS INC. (2)
- Chelsea Therapeutics International, Ltd. (2)
- CHF Solutions, Inc. (5)
- Cytosorbents Corp (1)
- Danaher Corp. (2)
- DarioHealth Corp. (1)
- DELCATH SYSTEMS, INC. (3)
- EKSO BIONICS HOLDINGS, INC. (2)
- ENDOLOGIX INC (2)
- ESTABLISHMENT LABS HOLDINGS INC. (1)
- GUIDED THERAPEUTICS INC (1)
- Hancock Jaffe Laboratories, Inc. (5)
- Heart Test Laboratories, Inc. (1)
- HELIUS MEDICAL TECHNOLOGIES, INC. (3)
- Innovative Eyewear Inc (1)
- InspireMD, Inc. (5)
- INVIVO THERAPEUTICS HOLDINGS CORP. (1)
- INVO Bioscience, Inc. (3)
- Medtronic plc (1)
- Microbot Medical Inc. (4)
- Motus GI Holdings, Inc. (2)
- MYOMO INC (2)
- Nemaura Medical Inc. (2)
- Neogen Corporation (1)
- OBALON THERAPEUTICS INC (1)
- PAVmed Inc. (4)
- Precision Therapeutics Inc. (4)
- REPROS THERAPEUTICS INC. (1)
- ReShape Lifesciences Inc. (1)
- SANUWAVE Health, Inc. (1)
- SECOND SIGHT MEDICAL PRODUCTS INC (1)
- Sintx Technologies, Inc. (1)
- Soliton, Inc. (2)
- STRATA Skin Sciences, Inc. (1)
- TearLab Corp (1)
- Tenon Medical, Inc. (1)
- Tivic Health Systems, Inc. (3)
- Zimmer Biomet Holdings (1)
- Form of Placement Agency Agreement (OBALON THERAPEUTICS INC, Filed With SEC on September 12, 2023)
- Placement Agency Agreement, dated as of August 24, 2023, by and between Myomo, Inc. and A.G.P./Alliance Global Partners (MYOMO INC, Filed With SEC on August 28, 2023)
- Form of Placement Agency Agreement (BIOLASE, INC, Filed With SEC on August 14, 2023)
- Placement Agency Agreement, dated August 6, 2023, by and between Tivic Health Systems, Inc. and Maxim Group LLC (Tivic Health Systems, Inc., Filed With SEC on August 9, 2023)
- Placement Agency Agreement by and between the Company and the Placement Agent dated August 4, 2023 (INVO Bioscience, Inc., Filed With SEC on August 8, 2023)
- Form of Placement Agency Agreement (INVO Bioscience, Inc., Filed With SEC on July 31, 2023)
- Placement Agency Agreement, dated July 14, 2023, by and between Tivic Health Systems, Inc. and Maxim Group LLC (Tivic Health Systems, Inc., Filed With SEC on July 19, 2023)
- Placement Agency Agreement, dated July 10, 2023, by and between Tivic Health Systems, Inc. and Maxim Group LLC (Tivic Health Systems, Inc., Filed With SEC on July 11, 2023)
- Form of Placement Agency Agreement (Innovative Eyewear Inc, Filed With SEC on June 16, 2023)
- Form of Placement Agency Agreement by and between Heart Test Laboratories, Inc. and Maxim Group LLC, as exclusive placement agent thereunder (Heart Test Laboratories, Inc., Filed With SEC on June 7, 2023)
- Form of Placement Agency Agreement (Tenon Medical, Inc., Filed With SEC on June 7, 2023)
- Placement Agency Agreement by and between the Company and the Placement Agent dated March 23, 2023 (INVO Bioscience, Inc., Filed With SEC on March 28, 2023)
- Placement Agency Agreement by and between Myomo, Inc. and AGP/ Alliance Global Partners dated January 11, 2023 (MYOMO INC, Filed With SEC on January 13, 2023)
- Placement Agency Agreement dated as of August 5, 2022 by and between Helius Medical Technologies, Inc. and Roth Capital Partners, LLC (HELIUS MEDICAL TECHNOLOGIES, INC., Filed With SEC on August 9, 2022)
- Form of Placement Agency Agreement (HELIUS MEDICAL TECHNOLOGIES, INC., Filed With SEC on July 27, 2022)
- Placement Agency Agreement, dated June 27, 2022, by and among the Company and Maxim Group LLC (BIOLASE, INC, Filed With SEC on June 29, 2022)
- Form of Placement Agency Agreement (Hancock Jaffe Laboratories, Inc., Filed With SEC on September 8, 2021)
- Placement Agency Agreement, dated, March 23, 2021, between the Company and ThinkEquity (SECOND SIGHT MEDICAL PRODUCTS INC, Filed With SEC on March 26, 2021)
- Placement Agency Agreement (PAVmed Inc., Filed With SEC on January 6, 2021)
- Placement Agency Agreement (PAVmed Inc., Filed With SEC on December 18, 2020)
- Placement Agency Agreement (PAVmed Inc., Filed With SEC on December 11, 2020)
- Form of Placement Agency Agreement (Hancock Jaffe Laboratories, Inc., Filed With SEC on October 8, 2020)
- Placement Agency Agreement, dated as of August 28, 2020, by and between A.G.P./Alliance Global Partners (Motus GI Holdings, Inc., Filed With SEC on August 28, 2020)
- Placement Agency Agreement, dated July 28, 2020, by and between the Company and Kingswood Capital Markets (Nemaura Medical Inc., Filed With SEC on July 30, 2020)
- Placement Agency Agreement dated as of June 8, 2020 by and among the Company, maxim group LLC, The Benchmark Company, LLC and Colliers Securities , LLC (BIOLASE, INC, Filed With SEC on June 9, 2020)
- Form of Placement Agency Agreement (Hancock Jaffe Laboratories, Inc., Filed With SEC on June 3, 2020)
- Placement Agency Agreement, dated as of May 1, 2020, by and between CHF Solutions, Inc. and Ladenburg Thalmann & Co. Inc (CHF Solutions, Inc., Filed With SEC on May 4, 2020)
- Form of Placement Agency Agreement (Hancock Jaffe Laboratories, Inc., Filed With SEC on April 28, 2020)
- Placement Agency Agreement, dated as of March 30, 2020, by and between CHF Solutions, Inc. and Ladenburg Thalmann & Co. Inc (CHF Solutions, Inc., Filed With SEC on March 30, 2020)
- Placement Agency Agreement, dated as of March 19, 2020, by and between CHF Solutions, Inc. and Ladenburg Thalmann & Co. Inc (CHF Solutions, Inc., Filed With SEC on March 20, 2020)
- Placement Agency Agreement by and between DarioHealth Corp. and Aegis Capital Corp. dated October 22, 2019 (DarioHealth Corp., Filed With SEC on March 17, 2020)
- Placement Agency Agreement (INVIVO THERAPEUTICS HOLDINGS CORP., Filed With SEC on November 22, 2019)
- Agency Agreement, dated as of November 15, 2019, by and between Zimmer Biomet Holdings, Inc., as issuer, Elavon Financial Services DAC, UK Branch, as paying agent, U.S. Bank... (Zimmer Biomet Holdings, Filed With SEC on November 15, 2019)
- Placement Agency Agreement, dated as of November 4, 2019, by and between CHF Solutions, Inc. and Ladenburg Thalmann & Co. Inc (CHF Solutions, Inc., Filed With SEC on November 4, 2019)
- Placement Agency Agreement, dated as of October 23, 2019, by and between CHF Solutions, Inc. and Ladenburg Thalmann & Co. Inc (CHF Solutions, Inc., Filed With SEC on October 23, 2019)
- Co-Placement Agency Agreement between Soliton, Inc. and Roth Capital Partners, LLC, Boustead Securities, LLC, and Maxim Group LLP dated October 10, 2019 (Soliton, Inc., Filed With SEC on October 15, 2019)
- Placement Agency Agreement (Precision Therapeutics Inc., Filed With SEC on October 10, 2019)
- Co-Placement Agency Agreement between Soliton, Inc. and Roth Capital Partners, LLC, Boustead Securities, LLC, and Maxim Group LLP dated June 16, 2019 (Soliton, Inc., Filed With SEC on June 18, 2019)
- Form of Placement Agency Agreement, between the Company and the placement agent (Hancock Jaffe Laboratories, Inc., Filed With SEC on June 7, 2019)
- Placement Agency Agreement (PAVmed Inc., Filed With SEC on April 12, 2019)
